NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 222 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.12 and the average weighting 0.2%.

Quarter-by-quarter ownership
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2022$2,000
-33.3%
80
-7.0%
0.00%
Q2 2021$3,000
+200.0%
86
+7.5%
0.00%
Q1 2020$1,000
-66.7%
80
-18.4%
0.00%
Q2 2019$3,000
+50.0%
98
+117.8%
0.00%
Q1 2019$2,000
-84.6%
45
-91.3%
0.00%
Q4 2016$13,000
+8.3%
518
-9.0%
0.00%
Q2 2016$12,000
+20.0%
569
-16.1%
0.00%
Q1 2016$10,0006780.00%
Other shareholders
SUPERNUS PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
ASHFORD CAPITAL MANAGEMENT INC 698,676$41,816,0005.51%
Provident Investment Management, Inc. 543,194$32,510,0004.61%
NEUMEIER POMA INVESTMENT COUNSEL LLC 426,250$25,511,0002.37%
KOPP INVESTMENT ADVISORS LLC 41,879$2,506,0002.35%
AlphaOne Investment Services, LLC 126,279$7,558,0002.17%
Ranger Investment Management 468,933$28,066,0001.96%
Bruce & Co., Inc. 158,058$9,459,0001.88%
Penserra Capital Management LLC 244,371$29,030,0001.83%
SHAKER INVESTMENTS LLC/OH 49,642$2,971,0001.83%
Bridge City Capital, LLC 47,795$2,861,0001.81%
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders